site stats

J clin oncol. 1993 11:1269–1275

WebJ Clin Oncol. 1993; 11: 1269-1275 Scopus (438) PubMed Crossref Google Scholar O’Bryan R.M. Luce J.K. Talley R.W. et al. Phase II evaluation of adriamycin in human neoplasia. Cancer. 1973; 32: 1-8 Scopus (318) PubMed Crossref Google Scholar Bramwell V. Mourisden H. Santoro A. et al. WebJ Clin Oncol. 1993;11(8):1448–1457. 22. Simone J V. Treatment of meningeal leukemia. J Clin Oncol. 1984;2(5):357–358. 23. ... Leukemia. 1994;8(8):1269–1274. 32. Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukaemia: determination of prognostic significance of rarer recurring ...

An intergroup phase III randomized study of doxorubicin …

WebOct 22, 2003 · In a subgroup analysis of patients with leiomyosarcoma histology, there was an objective response rate of 18% (2 of 11 patients), with disease stabilization occurring … WebNov 3, 1993 · 10.1200/JCO.1993.11.3.554 Abstract Purpose: The tolerance of escalating targeted doses of carboplatin combined with ifosfamide (IFOS)/etoposide (VP-16) (ICE) was assessed in children with recurrent solid tumors. Patients and methods: mgc car toys https://pazzaglinivivai.com

Spine 2010 35 e1221e1229 crossref 78 avrahami e - Course Hero

WebApr 18, 2007 · Single-agent gemcitabine and vinorelbine have activity in treatment of patients with soft-tissue sarcomas. The combination of gemcitabine plus vinorelbine has … WebCharlotte's All-Black Schools. Marie G. Davis School was originally an elementary school for black children on the south side of town. It was named for a former teacher. After … WebSpine 2010 35 E1221E1229 CrossRef 78 Avrahami E Tadmor R Dally O Hadar H Early from PHYS 111 at University of Toronto how to calculate hra from basic salary

Soft Tissue Sarcoma: Diagnosis and Treatment

Category:Phase I multicenter study of combined high-dose ifosfamide and ...

Tags:J clin oncol. 1993 11:1269–1275

J clin oncol. 1993 11:1269–1275

New and emerging therapies for advanced or metastatic soft …

WebMar 5, 2014 · Whether doxorubicin alone or the combination of doxorubicin and ifosfamide should be used routinely is still controversial. We assessed whether dose intensification … WebJun 7, 2024 · Synovial sarcoma is a rare malignant tumor that generally requires a multidisciplinary therapeutic approach. In this study we report the experience of a single surgeon, evaluating surgical and oncological outcomes of the cases he treated through his 30 years carrier. Methods We enrolled patients treated surgically between 1988 and 2024.

J clin oncol. 1993 11:1269–1275

Did you know?

WebJ Clin Oncol 11: 1269–1275, 1993. PubMed CAS Google Scholar Santoro A, Tursz T, Mouridsen H, et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: A randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma … WebJ Clin Oncol 1993, 11 :1269–1275. PubMed CAS Google Scholar Baker LH, Frank J, Fine G, et al.: Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and …

WebApr 20, 2024 · J Clin Oncol. 1993;11:1276–1285. 4. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta … WebNov 15, 2024 · J Clin Oncol. 1993; 11(7): 1276–1285. pmid:8315425 . View Article ... and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 1993; 11(7): 1269–1275. pmid:8315424 . View Article PubMed/NCBI Google Scholar 14. Stacchiotti S, Dagrada GP, Sanfilippo R, Negri T, Vittimberga I, Ferrari S, et al. Anthracycline-based chemotherapy in ...

WebNov 1, 2004 · The unadjusted hazard ratio for the effect of NAC on disease-specific survival was 0.75 (95% CI: 0.45–1.2). Using the Cox proportional hazards model stratified by … WebJ Clin Oncol. 1993;11(7):1269–1275. 41. Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M; Members of the Sarcoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma.

WebNov 7, 1993 · DOI: 10.1200/JCO.1993.11.7.1276. Abstract. Purpose and methods: Doxorubicin alone or with dacarbazine (DTIC; AD) is considered the best available therapy …

WebSep 12, 2016 · J Clin Oncol 11: 1269-1275, 1993 Link, Google Scholar: 7. Antman K, Crowley J, Balcerzak SP, et al: An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 11: 1276-1285, 1993 Link, Google Scholar: 8. how to calculate hra from gross salaryWebOct 10, 2006 · Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR (1993) ... J Clin Oncol 11: 1269–1275. CAS Article Google Scholar Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D ... mgccc andrews hallWebGoogle Scholar. Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or … mgccc augusoft netWebMost cited. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L) mgccc athletic directorWebSep 12, 2016 · J Clin Oncol 11: 1269-1275, 1993 Link, Google Scholar 7. Antman K , Crowley J , Balcerzak SP , et al: An intergroup phase III randomized study of doxorubicin and … how to calculate hrdf levyWebMar 1, 2005 · J Clin Oncol 1993; 11: 1269 – 1275. Edmonson JH Ryan LM Blum RH . Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or … mgcc cape townWebAt Levine Cancer Institute, your well-being is always our top priority. From extensive cleaning protocols to coronavirus screenings for staff and patients, we’re doing everything we can … how to calculate hra in tax